Crossmark

The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsies

Crossref DOI link: https://doi.org/10.1186/s13000-019-0840-2

Published Online: 2019-06-21

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ho, Hsiang-Ling

Kao, Hua-Lin

Yeh, Yi-Chen

Chou, Teh-Ying
License Information

Text and Data Mining valid from 2019-06-21

Version of Record valid from 2019-06-21
More Information

Article History

Received: 22 February 2019

Accepted: 11 June 2019

First Online: 21 June 2019

Ethics approval and consent to participate

: This study was approved by the Institutional Review Board of Taipei Veterans General Hospital (2017–05-008CC). Formal patient consent was waived because of the retrospective study design.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below